Global Genomics Market Overview:
Global Genomics Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Genomics Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Genomics involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Genomics Market:
The Genomics Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Genomics Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Genomics Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Genomics market has been segmented into:
Functional Genomics
Epigenomics
Pathway Analysis and Biomarker Discovery
By Application, Genomics market has been segmented into:
Clinical Research
Academic & Government Institutes
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies and Other End Users
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Genomics market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Genomics market.
Top Key Players Covered in Genomics market are:
Agilent Technologies
Bio-Rad Laboratories
Inc.
BGI Genomics
Color Genomics
Inc.
Danaher Corporation
Eppendorf AG
Eurofins Scientific
Hoffmann-La Roche Ltd.
GE Healthcare
Illumina
Inc.
Myriad Genetics
Inc.
Oxford Nanopore Technologies
Pacific Biosciences of California
Inc.
QIAGEN N.V.
Quest Diagnostics Incorporated
Thermo Fisher Scientific
Inc.
23andMe
Inc.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Genomics Market Type
4.1 Genomics Market Snapshot and Growth Engine
4.2 Genomics Market Overview
4.3 Functional Genomics
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Functional Genomics: Geographic Segmentation Analysis
4.4 Epigenomics
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Epigenomics: Geographic Segmentation Analysis
4.5 Pathway Analysis and Biomarker Discovery
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Pathway Analysis and Biomarker Discovery: Geographic Segmentation Analysis
Chapter 5: Genomics Market Application
5.1 Genomics Market Snapshot and Growth Engine
5.2 Genomics Market Overview
5.3 Clinical Research
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Clinical Research: Geographic Segmentation Analysis
5.4 Academic & Government Institutes
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Academic & Government Institutes: Geographic Segmentation Analysis
5.5 Hospitals & Clinics
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Hospitals & Clinics: Geographic Segmentation Analysis
5.6 Pharmaceutical & Biotechnology Companies and Other End Users
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Pharmaceutical & Biotechnology Companies and Other End Users: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Genomics Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 AGILENT TECHNOLOGIES
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 BIO-RAD LABORATORIES
6.4 INC.
6.5 BGI GENOMICS
6.6 COLOR GENOMICS
6.7 INC.
6.8 DANAHER CORPORATION
6.9 EPPENDORF AG
6.10 EUROFINS SCIENTIFIC
6.11 HOFFMANN-LA ROCHE LTD.
6.12 GE HEALTHCARE
6.13 ILLUMINA
6.14 INC.
6.15 MYRIAD GENETICS
6.16 INC.
6.17 OXFORD NANOPORE TECHNOLOGIES
6.18 PACIFIC BIOSCIENCES OF CALIFORNIA
6.19 INC.
6.20 QIAGEN N.V.
6.21 QUEST DIAGNOSTICS INCORPORATED
6.22 THERMO FISHER SCIENTIFIC
6.23 INC.
6.24 23ANDME
6.25 INC.
Chapter 7: Global Genomics Market By Region
7.1 Overview
7.2. North America Genomics Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Functional Genomics
7.2.2.2 Epigenomics
7.2.2.3 Pathway Analysis and Biomarker Discovery
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Clinical Research
7.2.3.2 Academic & Government Institutes
7.2.3.3 Hospitals & Clinics
7.2.3.4 Pharmaceutical & Biotechnology Companies and Other End Users
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Genomics Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Functional Genomics
7.3.2.2 Epigenomics
7.3.2.3 Pathway Analysis and Biomarker Discovery
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Clinical Research
7.3.3.2 Academic & Government Institutes
7.3.3.3 Hospitals & Clinics
7.3.3.4 Pharmaceutical & Biotechnology Companies and Other End Users
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Genomics Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Functional Genomics
7.4.2.2 Epigenomics
7.4.2.3 Pathway Analysis and Biomarker Discovery
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Clinical Research
7.4.3.2 Academic & Government Institutes
7.4.3.3 Hospitals & Clinics
7.4.3.4 Pharmaceutical & Biotechnology Companies and Other End Users
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Genomics Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Functional Genomics
7.5.2.2 Epigenomics
7.5.2.3 Pathway Analysis and Biomarker Discovery
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Clinical Research
7.5.3.2 Academic & Government Institutes
7.5.3.3 Hospitals & Clinics
7.5.3.4 Pharmaceutical & Biotechnology Companies and Other End Users
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Genomics Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Functional Genomics
7.6.2.2 Epigenomics
7.6.2.3 Pathway Analysis and Biomarker Discovery
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Clinical Research
7.6.3.2 Academic & Government Institutes
7.6.3.3 Hospitals & Clinics
7.6.3.4 Pharmaceutical & Biotechnology Companies and Other End Users
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Genomics Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Functional Genomics
7.7.2.2 Epigenomics
7.7.2.3 Pathway Analysis and Biomarker Discovery
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Clinical Research
7.7.3.2 Academic & Government Institutes
7.7.3.3 Hospitals & Clinics
7.7.3.4 Pharmaceutical & Biotechnology Companies and Other End Users
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Genomics Scope:
|
Report Data
|
Genomics Market
|
|
Genomics Market Size in 2025
|
USD XX million
|
|
Genomics CAGR 2025 - 2032
|
XX%
|
|
Genomics Base Year
|
2024
|
|
Genomics Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Agilent Technologies, Bio-Rad Laboratories, Inc., BGI Genomics, Color Genomics, Inc., Danaher Corporation, Eppendorf AG, Eurofins Scientific, Hoffmann-La Roche Ltd., GE Healthcare, Illumina, Inc., Myriad Genetics, Inc., Oxford Nanopore Technologies, Pacific Biosciences of California, Inc., QIAGEN N.V., Quest Diagnostics Incorporated, Thermo Fisher Scientific, Inc., 23andMe, Inc..
|
|
Key Segments
|
By Type
Functional Genomics
Epigenomics
Pathway Analysis and Biomarker Discovery
By Applications
Clinical Research
Academic & Government Institutes
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies and Other End Users
|
